Oculis to Present at the Stifel 2024 Healthcare Conference

Company Overview - Oculis Holding AG is a global biopharmaceutical company focused on saving sight and improving eye care [3] - The company has a differentiated pipeline with multiple innovative product candidates, including OCS-01 for diabetic macular edema and post-cataract surgery inflammation, licaminlimab (OCS-02) for dry eye disease and non-infectious anterior uveitis, and OCS-05 for acute optic neuritis [3] - Oculis is headquartered in Switzerland and operates in the U.S. and Iceland, aiming to enhance the health and quality of life for patients globally [3] Upcoming Events - Oculis management will participate in the Stifel 2024 Healthcare Conference on November 18-19, 2024, at the Lotte New York Palace Hotel [1] - CFO Sylvia Cheung will engage in a fireside chat on November 18, 2024, at 3:35 pm ET, with a live webcast available [2] - The company will also hold one-on-one meetings during the conference for interested investors [2]